Health
“The new ASH 2026 guidelines increased the iron deficiency (measured by ferritin, iron stores) cut off from 15 to 30 ng/mL, and actually to 50 ng/mL in people with heavy periods or other symptoms. This is a big change!" (accompanied by a list of symptoms including hair shedding, pale skin, bluish undereyes, feeling cold, fast heartbeat…”
Plain restatementThe American Society of Hematology's 2026 clinical practice guideline on diagnosing iron deficiency suggests a serum ferritin diagnostic threshold of 30 ng/mL or lower for adults, replacing the previously common 15 ng/mL threshold, and a higher threshold of 50 ng/mL or lower for people with heavy menstrual bleeding or with signs, symptoms or risk factors of iron deficiency.
General information only - not medical advice.
The main numbers in this post are right. The American Society of Hematology published new guidelines in September 2026 that set the ferritin cutoff for diagnosing iron deficiency in adults at 30 ng/mL or lower, replacing the 15 ng/mL figure that laboratories and the World Health Organization had widely used, and a higher cutoff of 50 ng/mL or lower for groups such as people with heavy menstrual bleeding, people with symptoms or risk factors, and pregnant people with anemia. It is also correct that these thresholds apply even when someone does not have anemia, so a normal blood count does not rule iron deficiency out. What the post leaves out is that nearly all of the recommendations are conditional and based on low or very low certainty evidence, and that ASH says ferritin should be read alongside symptoms, inflammation and risk factors rather than as a standalone number. This is also ASH's first guideline on diagnosing iron deficiency, not a revision of an earlier ASH figure. The symptom list goes further than the evidence: pale skin, fast heartbeat and shortness of breath are recognised, but "bluish undereyes" is a social-media idea rather than a guideline sign, and the link between low iron and hair shedding is an association in observational studies rather than a proven cause. Guidance on treating iron deficiency is expected from ASH in 2027, and any decision about testing or treatment is one to take with a clinician. General information only, not medical advice.
The [drifted from the evidence:] new ASH 2026 [drifted from the evidence:] guidelines increased the iron deficiency [drifted from the evidence:] (measured by ferritin, [drifted from the evidence:] iron stores) cut off from 15 to 30 ng/mL, and [drifted from the evidence:] actually to 50 ng/mL [drifted from the evidence:] in people with heavy [drifted from the evidence:] periods or [drifted from the evidence:] other symptoms. This is a big change!" (accompanied by a list of symptoms [drifted from the evidence:] including hair shedding, pale skin, bluish undereyes, feeling cold, fast heartbeat and shortness of [drifted from the evidence:] breath)
The [added by the neutral restatement:] American Society of Hematology's 2026 [added by the neutral restatement:] clinical practice guideline on diagnosing iron deficiency [added by the neutral restatement:] suggests a serum ferritin [added by the neutral restatement:] diagnostic threshold of 30 ng/mL [added by the neutral restatement:] or lower for adults, replacing the previously common 15 ng/mL threshold, and [added by the neutral restatement:] a higher threshold of 50 ng/mL [added by the neutral restatement:] or lower for people with heavy [added by the neutral restatement:] menstrual bleeding or [added by the neutral restatement:] with signs, symptoms [added by the neutral restatement:] or risk factors of [added by the neutral restatement:] iron deficiency.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- ASH did release new evidence-based iron deficiency diagnosis guidelines in 2026, published in Blood Advances.
- The guidelines suggest a serum ferritin threshold of 30 ng/mL or lower for adults, explicitly instead of the previously used 15 ng/mL.
- A higher threshold of 50 ng/mL or lower applies to people with heavy menstrual bleeding and to adults with signs, symptoms or risk factors of iron deficiency, so the claim's "heavy periods or other symptoms" phrasing matches the guideline's scope reasonably well.
- The guidelines apply whether or not anemia is present, so the post's advice that a normal anemia workup does not rule out iron deficiency reflects what the guideline and its authors say.
- Shortness of breath, rapid heartbeat and pale skin are listed by ASH among iron deficiency symptoms.
- Characterizing this as a significant change is fair: the adult threshold doubles and ASH describes the aim as catching cases that were previously missed.
- Omitted qualifier: the post presents the thresholds as settled new rules. Four of the five recommendations are conditional and based on low or very low certainty evidence, and the guideline says ferritin should be interpreted with symptoms, inflammation status and risk factors rather than as a standalone number.
- Omitted qualifier: the 50 ng/mL threshold is not a blanket rule for anyone with symptoms. It is specified for defined groups such as heavy menstrual bleeding, abnormal uterine bleeding, upcoming surgery, planned pregnancy, other risk factors, and pregnancy with anemia.
- Slight framing stretch: "raised the cutoff" implies ASH revised its own earlier number. This is ASH's first evidence-based guideline on diagnosing iron deficiency; the 15 ng/mL figure it displaces came from WHO cutoffs and routine laboratory reference ranges.
- Unsupported causal inference in the symptom list: "bluish undereyes" is part of the social-media "ferritin face" idea rather than a guideline-listed sign, and mainstream reporting featuring the guideline's own chair treats visual self-diagnosis from under-eye circles as unreliable.
- Exaggeration regarding hair: iron deficiency is associated with hair shedding in observational studies, but stating it flatly as "a cause" overstates evidence that is associative and mixed rather than causal.
- The exact full text and recommendation numbering of the published Blood Advances article were not retrieved directly; verification rests on the ASH press release, ASH implementation and draft documents, and multiple independent summaries that agree on the numbers.
- Whether ASH's own wording anywhere frames the 50 ng/mL figure for non-menstruating adults as broadly as "other symptoms" could not be checked against the final published sentence, only against summaries and the draft recommendations.
- Whether raising thresholds improves patient outcomes, as opposed to increasing the number of people labeled iron deficient, is not established; ASH itself rates the evidence as low or very low certainty and treatment guidance is still pending for 2027.
- Whether correcting low ferritin reverses hair shedding in a given person is not resolved by the available evidence.
ASH published evidence-based clinical practice guidelines on the diagnosis of iron deficiency in September 2026 in Blood Advances. The guidelines set population-specific serum ferritin thresholds that apply whether or not anemia is present: 20 ng/mL or lower for children aged 9 months to 4 years, 30 ng/mL or lower for adults including menstruating and pregnant individuals, and 50 ng/mL or lower for selected higher-risk groups. The 50 ng/mL figure applies to adults with signs, symptoms or ongoing risk factors of iron deficiency, to menstruating individuals with heavy menstrual bleeding, abnormal uterine bleeding, associated symptoms, upcoming surgery or planned pregnancy, and to pregnant individuals with anemia. For adults with inflammation, such as cancer, inflammatory bowel disease or infection, the panel advises interpreting ferritin under 100 ng/mL or transferrin saturation under 20% rather than relying on ferritin alone. The prior widely used thresholds were approximately 12 ng/mL in young children and 15 ng/mL in older children and adults, aligned with World Health Organization cutoffs. ASH explicitly suggests 30 ng/mL instead of 15 ng/mL for non-pregnant, non-menstruating adults and for menstruating individuals, and in pregnancy recommends against the 15 ng/mL threshold. The guideline also states that iron deficiency can cause symptoms before hemoglobin falls, listing fatigue, weakness, shortness of breath, rapid heartbeat, headache, pale skin, impaired concentration, restless legs syndrome and pica. CNN coverage quoting guideline chair Dr. Jacquelyn Powers and Dr. Ariela Marshall notes that iron deficiency without anemia can cause symptoms and that a standard complete blood count will not detect it, while also reporting that people online are self-diagnosing from dark under-eye circles and pale skin, a social-media construct the article frames as not a reliable basis for self-diagnosis.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.
Ask this case
Answers come only from the case file above; nothing is added.
Did the ASH actually change the ferritin cutoff for iron deficiency?
Yes. In September 2026 ASH published new guidelines suggesting a ferritin threshold of 30 ng/mL or lower for adults, replacing the commonly used 15 ng/mL figure.
Is the 50 ng/mL threshold for anyone with any symptoms?
No. It applies to specific groups: people with heavy menstrual bleeding, abnormal uterine bleeding, upcoming surgery, planned pregnancy, other defined risk factors, adults with signs or symptoms of iron deficiency, and pregnant people with anemia, not to any symptom in general.
Does this mean a normal blood count rules out iron deficiency?
No. The guidelines apply whether or not anemia is present, so a standard complete blood count can look normal while someone still has iron deficiency by these new ferritin thresholds.
Does low iron actually cause hair shedding and bluish undereyes?
Shortness of breath, rapid heartbeat and pale skin are listed by ASH as iron deficiency symptoms, but bluish undereyes is not a guideline-listed sign, it is a social media idea. Hair shedding has been associated with low iron in observational studies, but the case file does not establish that low iron causes it.
How solid is the evidence behind these new thresholds?
Most of the recommendations are conditional and rated as low or very low certainty evidence by ASH, and the guideline says ferritin should be interpreted alongside symptoms, inflammation and risk factors rather than used as a standalone number.